The Patent Finder

ADIENNE Pharma & Biotech SA

Also on record
Records under this name other than the patents ADIENNE Pharma & Biotech SA holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.

Showing 1 to 2 of 2 · Back to ADIENNE Pharma & Biotech SA

PatentTitleStatus Expires Confidence
US 9,976,151Artificial DNA sequence with optimized leader function in 5′(5′-UTR) for the over-expression of recombinant proteins in plants and method for the production of recombinant proteins in plants
Lapsed on the fee record
Ended May 22, 2026 · From the USPTO record
Lapsed on the fee recordEnded May 22, 2026From the USPTO record
US 9,085,775Artificial DNA sequence with optimized leader function in 5′ (5′-UTR) for the improved expression of heterologous proteins in plants
Lapsed on the fee record
Ended Jul 21, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jul 21, 2023From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited